Answers are grounded in this paper and cite their sources.
Randomized trial evaluates survival outcomes from surgical strategies in elderly patients with ovarian cancer, indicating limited benefits.
Elderly patients with ovarian cancer are underrepresented in clinical trials and often receive less intensive treatment. The role of cytoreductive surgery, particularly interval debulking surgery (IDS), in this population remains unclear. We aimed to evaluate real-world outcomes and the impact of surgical strategies in elderly patients with epithelial ovarian cancer.
No takes yet. Share an insight, caveat, or question.
Liontos et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: